Category NEWS

TG Therapeutics

TG Therapeutics Publishes Five-Year Comparative Analysis of BRIUMVI in Relapsing Multiple Sclerosis

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis TG Therapeutics, Inc. announced the publication of results from a five-year matching-adjusted indirect comparison (MAIC) evaluating long-term relapse activity and disability progression…

Read MoreTG Therapeutics Publishes Five-Year Comparative Analysis of BRIUMVI in Relapsing Multiple Sclerosis
Italfarmaco

Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases

Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and…

Read MoreItalfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases
Italfarmaco

Italfarmaco and JCR Pharmaceuticals Sign Exclusive License Deal for Hunter Syndrome Therapy

Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for the Development and Potential Commercialization of Novel Investigational Therapy for Hunter Syndrome in the United States, Europe, and Latin America Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. announced an exclusive…

Read MoreItalfarmaco and JCR Pharmaceuticals Sign Exclusive License Deal for Hunter Syndrome Therapy
Vividion

Vividion Publishes VVD-214 Clinical Data in Nature Medicine, Highlighting Its Potential for Colorectal Cancer

Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer Vividion Therapeutics, Inc. a clinical-stage biopharmaceutical company and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of the…

Read MoreVividion Publishes VVD-214 Clinical Data in Nature Medicine, Highlighting Its Potential for Colorectal Cancer
Estée

Estée Lauder and Breast Cancer Research Foundation Launch Major Global Study on Breast Cancer in Younger Women

The Estée Lauder Companies and the Breast Cancer Research Foundation Launch Largest Global Research Initiative on Breast Cancer in Younger Women The Estée Lauder Companies announced a new five-year commitment to the Breast Cancer Research Foundation to establish the Global…

Read MoreEstée Lauder and Breast Cancer Research Foundation Launch Major Global Study on Breast Cancer in Younger Women
Refrigeration

Refrigeration Technologies Launches Viper Drainado 15-in-1 Tool for HVACR and Plumbing Drain Lines

Refrigeration Technologies Introduces Viper Drainado 15-in-1 Tool for HVACR Condensate Lines and Plumbing Drains Refrigeration Technologies, the Southern California-based manufacturer behind the Viper® line of non-toxic HVACR chemical solutions, today announced the launch of Viper Drainado™, a 15-in-1 adapter that…

Read MoreRefrigeration Technologies Launches Viper Drainado 15-in-1 Tool for HVACR and Plumbing Drain Lines
Merz Therapeutics

Merz Therapeutics Secures EU/EEA Approval for XEOMIN® to Treat Pediatric Spasticity Linked to Pes Equinus

Merz Therapeutics Receives EU/EEA Approval for XEOMIN® for the Treatment of Pediatric Spasticity Associated With Pes Equinus Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced that it has received approval in the European Union (EU) / European Economic…

Read MoreMerz Therapeutics Secures EU/EEA Approval for XEOMIN® to Treat Pediatric Spasticity Linked to Pes Equinus
AESARA

AESARA Names Denise Sánchez as Vice President of Regulatory Counsel and Compliance

AESARA Appoints Denise Sánchez as Vice President, Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served…

Read MoreAESARA Names Denise Sánchez as Vice President of Regulatory Counsel and Compliance
Estée

Indianapolis Community Unites to Take Action Against Breast Cancer at Susan G. Komen® MORE THAN PINK Walk

Breast Cancer Continues to Impact Communities; Indianapolis Rallies Together to Take Action at the Susan G. Komen® MORE THAN PINK Walk Susan G. Komen®, the world’s leading breast cancer organization, announced it will host the Indianapolis MORE THAN PINK Walk bringing together…

Read MoreIndianapolis Community Unites to Take Action Against Breast Cancer at Susan G. Komen® MORE THAN PINK Walk